Pediatric Cancer

PEDIATRIC CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Does Larotrectinib Offer New Hope to Children With TRK Fusion-Positive Solid Tumors?

Because of the drug’s promising safety and efficacy, the first child was treated on trial only 9 months after the first adult with a TRK fusion was treated.
Recent Conference Highlights New Potential Targets for Pediatric Cancer Treatments

Advances in targeted therapy for pediatric patients were presented at the AACR Special Conference on Pediatric Cancer.

PEDIATRIC CANCER NEWS

Childhood cancer survivors exposed to therapies that cause pulmonary dysfunction are associated with

Higher Risk for Cancer, Mortality Seen With Pediatric-Onset IBD

May 14, 2019

A large, long-term study found a 97% event-free survival rate at 18 months.

Less Postoperative Chemotherapy for Pediatric Hepatoblastoma Has No Effect on Disease Control

April 18, 2019

Potential Unintended Consequences of the “Right to Try” Act on the Delivery of Palliative Care to Children With Cancer

March 15, 2019

The continuous decline in cancer deaths over the past 25 years was attributed to improvements in scr

“Real-World” Hospitalization Data on Patients Receiving CAR-T Cell Therapy

March 7, 2019

A large, long-term study found a 97% event-free survival rate at 18 months.

The Price Is Right for CAR-T in Pediatric Patients, Analysis Concludes

October 19, 2018

Next post in Pediatric Cancer

The continuous decline in cancer deaths over the past 25 years was attributed to improvements in scr

“Real-World” Hospitalization Data on Patients Receiving CAR-T Cell Therapy